Døskeland A P, Martinez A, Knappskog P M, Flatmark T
Department of Biochemistry and Molecular Biology, University of Bergen, Norway.
Biochem J. 1996 Jan 15;313 ( Pt 2)(Pt 2):409-14. doi: 10.1042/bj3130409.
The phosphorylation of human phenylalanine hydroxylase by cyclic AMP-dependent protein kinase was studied using recombinant enzyme expressed as a fusion protein in the pMAL system of Escherichia coli. Using the target sequence of the restriction protease enterokinase (Asp4-Lys) as the linker peptide, 100% full-length human phenylalanine hydroxylase was obtained on protease cleavage. The fusion protein and human phenylalanine hydroxylase were both phosphorylated at Ser-16 with a stoichiometry of 1 mol of Pi/mol of subunit. The rate of phosphorylation of human phenylalanine hydroxylase was inhibited about 40% by the cofactor tetrahydrobiopterin, and this inhibition was completely prevented by the simultaneous presence of L-phenylalanine (i.e. at turnover conditions). Phosphorylated enzyme revealed a 1.6-fold higher specific activity than the non-phosphorylated enzyme form, and it also required a lower concentration of L-Phe for substrate activation. Pre-incubation with L-Phe increased the specific activity of phenylalanine hydroxylase 2- to 4-fold, L-Phe acting with positive cooperativity. Thus, the basic catalytic and regulatory properties of recombinant human phenylalanine hydroxylase, as well as those observed for the enzyme as a fusion protein, are similar to those previously reported for the rat liver enzyme. When the target sequence of the restriction protease factor Xa (Ile-Glu-Gly-Arg) was used as the linker between maltose-binding protein and human phenylalanine hydroxylase, cleavage of the fusion protein gave a mixture of full-length hydroxylase and a truncated form of the enzyme lacking the 13 N-terminal residues. Interestingly, phosphorylation of the fusion protein, before exposure to factor Xa, almost completely protected against secondary cleavage by this restriction protease at Arg-13 of phenylalanine hydroxylase.
利用在大肠杆菌的pMAL系统中作为融合蛋白表达的重组酶,研究了环磷酸腺苷依赖性蛋白激酶对人苯丙氨酸羟化酶的磷酸化作用。使用限制性蛋白酶肠激酶(天冬氨酸4-赖氨酸)的靶序列作为连接肽,经蛋白酶切割后获得了100%的全长人苯丙氨酸羟化酶。融合蛋白和人苯丙氨酸羟化酶均在丝氨酸-16处发生磷酸化,化学计量比为1摩尔磷酸根/摩尔亚基。辅因子四氢生物蝶呤对人苯丙氨酸羟化酶的磷酸化速率有大约40%的抑制作用,而L-苯丙氨酸的同时存在(即在周转条件下)可完全消除这种抑制作用。磷酸化酶的比活性比未磷酸化的酶形式高1.6倍,并且它也需要较低浓度的L-苯丙氨酸来激活底物。用L-苯丙氨酸预孵育可使苯丙氨酸羟化酶的比活性提高2至4倍,L-苯丙氨酸以正协同性起作用。因此,重组人苯丙氨酸羟化酶的基本催化和调节特性,以及作为融合蛋白观察到的那些特性,与先前报道的大鼠肝脏酶的特性相似。当使用限制性蛋白酶因子Xa(异亮氨酸-谷氨酸-甘氨酸-精氨酸)的靶序列作为麦芽糖结合蛋白与人苯丙氨酸羟化酶之间的连接子时,融合蛋白的切割产生了全长羟化酶和缺少13个N端残基的酶的截短形式的混合物。有趣的是,在融合蛋白暴露于因子Xa之前对其进行磷酸化,几乎完全防止了这种限制性蛋白酶在苯丙氨酸羟化酶的精氨酸-13处进行二次切割。